Ozempic Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
17:30
Jan 07
Jan 07
Better diets reduce weight-loss drug demand.
Most-favored-nation pricing has already cut GLP-1 prices, but the administration's real goal is to reduce demand for drugs by improving diets; better nutrition from the new guidelines should reduce the need to buy weight-loss drugs like Ozempic and expensive autoimmune drugs, creating a negative demand outlook for GLP-1 weight-loss drugs.
HIGH
About Ozempic Investor Commentary
Across the available history and selected sources, Buzzberg tracks Ozempic across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Mehmet Oz.